logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

China Starch (03838) spent 372,000 Hong Kong dollars on May 14 to repurchase 2 million shares.

date
17:42 14/05/2026
avatar
GMT Eight
China Starch (03838) announced that the company repurchased 2 million shares on May 14, 2026 at a cost of HK$372,000, with a repurchase price of HK$0.186 per share.
CHINA STARCH (03838) has announced that the company will spend 372,000 HK dollars to repurchase 2 million shares on May 14, 2026, at a repurchase price of 0.186 HK dollars per share.
Related Articles
China Stock
Guosheng: Cross-border securities business regulation tightens again, positive about the value of insurance sector allocation.
China Stock
Sinotherapeutics Inc. (688247.SH): Hydrochloric acid Alprazolam sustained-release tablets obtained approval number from Colombia INVIMA.
China Stock
Tianjin Tianyao Pharmaceuticals' subsidiary, Beimei Prostaglandin Eye Drops, has obtained a drug registration certificate.
Guosheng: Cross-border securities business regulation tightens again, positive about the value of insurance sector allocation.
China Stock
Sinotherapeutics Inc. (688247.SH): Hydrochloric acid Alprazolam sustained-release tablets obtained approval number from Colombia INVIMA.
China Stock
Tianjin Tianyao Pharmaceuticals' subsidiary, Beimei Prostaglandin Eye Drops, has obtained a drug registration certificate.
China Stock
RECOMMEND
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
icon
21/05/2026
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
icon
21/05/2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
icon
21/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.